Ksenia A. Orlova, Ph.D.
Affiliations: | University of Pennsylvania, Philadelphia, PA, United States |
Area:
Epilepsy (Tuberous Sclerosis)Google:
"Ksenia Orlova"Mean distance: 20.17 (cluster 17)
Parents
Sign in to add mentor| Peter Crino | grad student | 2009 | Penn | |
| (The function of STRADalpha during corticogenesis: Insights into the neuropathogenesis of focal cortical dysplasias.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tsai V, Parker WE, Orlova KA, et al. (2014) Fetal brain mTOR signaling activation in tuberous sclerosis complex. Cerebral Cortex (New York, N.Y. : 1991). 24: 315-27 |
| Parker WE, Orlova KA, Parker WH, et al. (2013) Rapamycin prevents seizures after depletion of STRADA in a rare neurodevelopmental disorder. Science Translational Medicine. 5: 182ra53 |
| Parker WE, Orlova KA, Heuer GG, et al. (2011) Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex. The American Journal of Pathology. 178: 296-305 |
| Orlova KA, Tsai V, Baybis M, et al. (2010) Early progenitor cell marker expression distinguishes type II from type I focal cortical dysplasias. Journal of Neuropathology and Experimental Neurology. 69: 850-63 |
| Hamamdzic D, Fenning RS, Patel D, et al. (2010) Akt pathway is hypoactivated by synergistic actions of diabetes mellitus and hypercholesterolemia resulting in advanced coronary artery disease. American Journal of Physiology. Heart and Circulatory Physiology. 299: H699-706 |
| Orlova KA, Parker WE, Heuer GG, et al. (2010) STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. The Journal of Clinical Investigation. 120: 1591-602 |
| Orlova KA, Crino PB. (2010) The tuberous sclerosis complex. Annals of the New York Academy of Sciences. 1184: 87-105 |